PP2A-Aβ Inhibitors

PP2A-Aβ inhibitors constitute a chemical class of compounds meticulously designed to disrupt the intricate biochemical interactions between Protein Phosphatase 2A (PP2A) and Amyloid-β (Aβ), critical players implicated in the pathogenesis of neurodegenerative diseases, particularly Alzheimer's disease. This category encompasses a wide array of chemical entities, spanning small molecules to naturally occurring compounds, each engineered to specifically target the molecular crosstalk between PP2A and Aβ within neuronal cells. At their core, these inhibitors are engineered to perturb the enzymatic functions of PP2A, a central enzyme in dephosphorylating various proteins, including Aβ, crucial in the aggregation and neurotoxicity processes associated with neurodegenerative diseases.

The structural composition of PP2A-Aβ inhibitors is characterized by a diverse array of chemical motifs, often featuring distinct functional groups that facilitate interactions with the active site of PP2A or disrupt the binding between PP2A and Aβ. These compounds exhibit an array of chemical backbones, such as heterocyclic rings, aromatic structures, or metal-chelating moieties, depending on their specific mechanism of action. Some inhibitors work directly by binding to the catalytic subunit of PP2A, rendering it less active, while others achieve their inhibitory effects indirectly by interfering with regulatory proteins like Cancerous Inhibitor of PP2A (CIP2A). Furthermore, certain inhibitors may possess additional properties, such as anti-inflammatory or antioxidant attributes. An in-depth comprehension of the nuanced structural features and intricate mechanisms of action of PP2A-Aβ inhibitors is pivotal for their development and refinement.